UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 251

Sortiert nach

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

Investigational new drugs, 2020-04, Vol.38 (2), p.402-409

2020

Volltextzugriff (PDF)

Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique

Revue des maladies respiratoires, 2014-02, Vol.31 (2), p.173-180

2014

Volltextzugriff (PDF)

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Annals of oncology, 2017-06, Vol.28 (6), p.1191-1206

2017

Volltextzugriff (PDF)

Ciblage pharmacologique de Mdm2 : bases biologiques et perspectives de radiosensibilisation

Cancer radiothérapie, 2011-07, Vol.15 (4), p.316-322

2011

Volltextzugriff (PDF)

Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii144

2018

Volltextzugriff (PDF)

3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2015-09, Vol.51, p.S647-S648

2015

Volltextzugriff (PDF)

467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01

European journal of cancer (1990), 2015-09, Vol.51, p.S101-S101

2015

Volltextzugriff (PDF)

A step towards the harmonization of clinical trials inform consent forms

Annals of oncology, 2017-05, Vol.28 (5), p.910-912

2017

Volltextzugriff (PDF)

3127 Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2015-09, Vol.51, p.S645-S646

2015

Volltextzugriff (PDF)

1306 POSTER Accuracy of Clinical Judgment of Progressive Disease in Phase II Trials

European journal of cancer (1990), 2011, Vol.47, p.S165-S165

2011

Volltextzugriff (PDF)

Computational medical imaging (radiomics) and potential for immuno-oncology

Cancer radiothérapie, 2017-10, Vol.21 (6-7), p.648-654

2017

Volltextzugriff (PDF)

Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

Annals of oncology, 2015-03, Vol.26 (3), p.582-588

2015

Volltextzugriff (PDF)

Chimiothérapie des métastases d'origine colorectale jamais résécables: stratégie multiligne, thérapies ciblées: DOSSIER DPC/CME : Le cancer du côlon : du dépistage de masse au traitement personnalisé

Oncologie (Paris, France), 2014, Vol.16 (11-12), p.579-586

2014

Volltextzugriff (PDF)

The situation of the DES of Medical Gynaecology in the Nord-Pas-de-Calais area (France)

Gynécologie, obstétrique & fertilité, 2010-03, Vol.38 (3), p.232-232

2010

Volltextzugriff (PDF)

FOLFIRI Chemotherapy in Patients with Advanced Non Resectable Esophageal or Junctional Adenocarcinoma: A Pilot Study

Journal of chemotherapy (Florence), 2011-12, Vol.23 (6), p.358-361

2011

Volltextzugriff (PDF)

FOLFIRIChemotherapy in Patients with Advanced Non Resectable Esophageal or Junctional Adenocarcinoma: A Pilot Study

Journal of chemotherapy (Florence), 2011-12, Vol.23 (6), p.358-361

2011

Volltextzugriff (PDF)

Management of the cardiovascular complications of treatment in thoracic oncology

Revue des maladies respiratoires, 2014-02, Vol.31 (2), p.173

2014

Volltextzugriff (PDF)

Preliminary Results From a Phase 2 Trial of Tipifarnib in HRAS-Mutant Head and Neck Squamous Cell Carcinomas

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1367-1367

2018

Volltextzugriff (PDF)

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma

Annals of oncology, 2010-06, Vol.21 (6), p.1385-1387

2010

Volltextzugriff (PDF)

Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research

Bulletin du cancer, 2009-04, Vol.96 (4), p.451

2009

Volltextzugriff (PDF)

Clinical equipoise and randomised clinical trials in oncology

Bulletin du cancer, 2009-06, Vol.96 (6), p.727

2009

Volltextzugriff (PDF)

High incidence of cetuximab-related infusion reactions in head and neck cancer pts (real life data)

Annals of oncology, 2016-10, Vol.27, p.vi335-vi335

2016

Volltextzugriff (PDF)

An advanced tumor shape radiomic signature predicts recurrence of locally advanced (LA) HNSCC patients (pts)

Annals of oncology, 2016-10, Vol.27, p.vi339-vi339

2016

Volltextzugriff (PDF)

Pharmacological targeting of Mdm2: rationale and perspectives for radiosensitization

Cancer radiothérapie, 2011-07, Vol.15 (4), p.316-322

2011

Volltextzugriff (PDF)

439PProspective validation of prognostic scores to improve patient selection for immuno-oncology trials

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(221)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(42)
Animals
(19)
Astronomy And Astrophysics
(19)
Humans
(19)
Physical Sciences
(19)
Sciences Biologiques Et Medicales
(18)
Physics
(16)
Oncology
(14)
Female
(13)
Astronomy & Astrophysics
(11)
Astrophysics
(11)
Biological And Medical Sciences
(11)
Life Sciences
(11)
Male
(11)
Sciences Biologiques Fondamentales Et Appliquees. Psychologie
(11)
France
(9)
Hematology, Oncology And Palliative Medicine
(9)
History
(9)
Biochemistry & Molecular Biology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Ciblage pharmacologique de Mdm2 : bases biologiques et perspectives de radiosensibilisation

Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials

3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)

467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01

A step towards the harmonization of clinical trials inform consent forms

3127 Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)

1306 POSTER Accuracy of Clinical Judgment of Progressive Disease in Phase II Trials

Computational medical imaging (radiomics) and potential for immuno-oncology

Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

Chimiothérapie des métastases d'origine colorectale jamais résécables: stratégie multiligne, thérapies ciblées: DOSSIER DPC/CME : Le cancer du côlon : du dépistage de masse au traitement personnalisé

The situation of the DES of Medical Gynaecology in the Nord-Pas-de-Calais area (France)

FOLFIRI Chemotherapy in Patients with Advanced Non Resectable Esophageal or Junctional Adenocarcinoma: A Pilot Study

FOLFIRIChemotherapy in Patients with Advanced Non Resectable Esophageal or Junctional Adenocarcinoma: A Pilot Study

Management of the cardiovascular complications of treatment in thoracic oncology

Preliminary Results From a Phase 2 Trial of Tipifarnib in HRAS-Mutant Head and Neck Squamous Cell Carcinomas

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma

Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research

Clinical equipoise and randomised clinical trials in oncology

High incidence of cetuximab-related infusion reactions in head and neck cancer pts (real life data)

An advanced tumor shape radiomic signature predicts recurrence of locally advanced (LA) HNSCC patients (pts)

Pharmacological targeting of Mdm2: rationale and perspectives for radiosensitization

439PProspective validation of prognostic scores to improve patient selection for immuno-oncology trials

Suchergebnisse filtern